STAT1 binds to the IRF promoter region in colon cancer cells, while MBD1 inhibits IRF8 expression (McGough et al., 2008), which is another indication evidence that WT1 in leukemia and IRF8 are anticorrelated (Vidovic et al., 2010). Here, IRF8 is linked to colonic neoplasm.